ArticleMetabolites2026

Malondialdehyde as a Predictor of Disease Severity and Cardiovascular Risk in Population with Metabolic Dysfunction-Associated Steatotic Liver Disease.

Roberto Lugo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.